ES548797A0 - Un procedimiento para la preparacion de sales de imidazolio. - Google Patents

Un procedimiento para la preparacion de sales de imidazolio.

Info

Publication number
ES548797A0
ES548797A0 ES548797A ES548797A ES548797A0 ES 548797 A0 ES548797 A0 ES 548797A0 ES 548797 A ES548797 A ES 548797A ES 548797 A ES548797 A ES 548797A ES 548797 A0 ES548797 A0 ES 548797A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
imidazole salts
imidazole
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES548797A
Other languages
English (en)
Other versions
ES8702370A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES8702370A1 publication Critical patent/ES8702370A1/es
Publication of ES548797A0 publication Critical patent/ES548797A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES548797A 1984-11-13 1985-11-12 Un procedimiento para la preparacion de sales de imidazolio. Expired ES8702370A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/670,776 US4609670A (en) 1984-11-13 1984-11-13 Imidazolium hypoglycemic agents

Publications (2)

Publication Number Publication Date
ES8702370A1 ES8702370A1 (es) 1987-01-01
ES548797A0 true ES548797A0 (es) 1987-01-01

Family

ID=24691822

Family Applications (1)

Application Number Title Priority Date Filing Date
ES548797A Expired ES8702370A1 (es) 1984-11-13 1985-11-12 Un procedimiento para la preparacion de sales de imidazolio.

Country Status (21)

Country Link
US (1) US4609670A (es)
EP (1) EP0182533B1 (es)
JP (1) JPH0647576B2 (es)
KR (1) KR880001231B1 (es)
CN (1) CN1013444B (es)
AR (1) AR244671A1 (es)
AT (1) ATE46505T1 (es)
AU (1) AU574532B2 (es)
CA (1) CA1266673A (es)
DE (1) DE3573114D1 (es)
DK (1) DK164547C (es)
EG (1) EG17707A (es)
ES (1) ES8702370A1 (es)
GR (1) GR852707B (es)
HU (1) HU195490B (es)
IE (1) IE59093B1 (es)
NZ (1) NZ214088A (es)
PH (1) PH21656A (es)
PT (1) PT81439B (es)
SU (1) SU1424733A3 (es)
ZA (1) ZA858499B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656261A (en) * 1995-01-18 1997-08-12 The Picower Institute For Medical Research Preventing and reversing advanced glycosylation endproducts
FI119756B (fi) * 1995-01-18 2009-03-13 Alteon Inc Tiatsoliumyhdisteiden käyttö pitkälle edenneen glykosylaation lopputuotteiden muodostumisen estossa ja suunnan muutoksessa
WO1996022095A2 (en) * 1995-01-18 1996-07-25 Alteon Inc. Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts
US20040198795A1 (en) * 1996-05-08 2004-10-07 Wagle Dilip R Substituted imidazoliums and methods of use therefor
US6121300A (en) 1998-11-10 2000-09-19 Wagle; Dilip R. Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts
US6781039B2 (en) * 2002-05-07 2004-08-24 Stine Seed Farm, Inc. Soybean cultivar S010360
DE102006028264B4 (de) * 2006-01-10 2008-12-11 Uwe Pisching Sägebock
CN100460395C (zh) * 2006-07-06 2009-02-11 云南大学 芳环和杂环酰甲基咪唑盐类化合物及其制备方法
CN102883607B (zh) * 2010-03-01 2015-07-22 Gtx公司 用于治疗癌的化合物
WO2020185928A1 (en) 2019-03-11 2020-09-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
KR20210143791A (ko) * 2019-03-11 2021-11-29 녹시온 테라퓨틱스 인코포레이티드 하전된 이온 채널 차단제 및 사용 방법
JP7513713B2 (ja) 2019-11-06 2024-07-09 ノシオン セラピューティクス，インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852301A (en) * 1973-06-21 1974-12-03 Squibb & Sons Inc Enol betaines of imidazoles
US4017631A (en) * 1974-11-19 1977-04-12 Janssen Pharmaceutica N.V. Imidazolium salts
GB1533706A (en) * 1976-03-01 1978-11-29 Ici Ltd Fungicidal imidazoles and 1,2,4-triazoles
DE2643563A1 (de) * 1976-09-28 1978-03-30 Bayer Ag Alpha-(4-biphenylyl)-benzyl-azolium- salze, verfahren zu ihrer herstellung sowie ihre verwendung zur bekaempfung von mikroorganismen
DE2714290A1 (de) * 1977-03-31 1978-10-05 Bayer Ag Fungizide mittel
JPS5479278A (en) * 1977-12-05 1979-06-25 Nippon Soda Co Ltd Imidazolium halide
JPS58150567A (ja) * 1982-03-03 1983-09-07 Kissei Pharmaceut Co Ltd 新規な１，３−二置換イミダゾ−ル誘導体およびその製造方法
US4581370A (en) * 1983-07-12 1986-04-08 Schering A.G. Antiarrhythmic imidazoliums

Also Published As

Publication number Publication date
CA1266673A (en) 1990-03-13
CN1013444B (zh) 1991-08-07
DE3573114D1 (en) 1989-10-26
ES8702370A1 (es) 1987-01-01
SU1424733A3 (ru) 1988-09-15
DK164547C (da) 1992-11-30
EP0182533A2 (en) 1986-05-28
PT81439B (pt) 1988-03-03
HUT39164A (en) 1986-08-28
KR860004029A (ko) 1986-06-16
EP0182533B1 (en) 1989-09-20
IE852822L (en) 1986-05-13
CN85108115A (zh) 1986-07-30
KR880001231B1 (ko) 1988-07-12
IE59093B1 (en) 1994-01-12
JPH0647576B2 (ja) 1994-06-22
PH21656A (en) 1988-01-13
PT81439A (en) 1985-12-01
DK515285A (da) 1986-05-14
DK515285D0 (da) 1985-11-08
EP0182533A3 (en) 1987-06-03
JPS61122212A (ja) 1986-06-10
DK164547B (da) 1992-07-13
US4609670A (en) 1986-09-02
AU4973785A (en) 1986-05-22
NZ214088A (en) 1988-09-29
GR852707B (es) 1986-03-10
AU574532B2 (en) 1988-07-07
ATE46505T1 (de) 1989-10-15
EG17707A (en) 1990-08-30
ZA858499B (en) 1987-06-24
AR244671A1 (es) 1993-11-30
HU195490B (en) 1988-05-30

Similar Documents

Publication Publication Date Title
ES544644A0 (es) Un procedimiento para la preparacion de derivados de carboxamidoadenosina.
ES531722A0 (es) Un procedimiento para la preparacion de derivados de fenetanolamina.
ES545464A0 (es) Un procedimiento para la preparacion de tetrahidroftalimidas.
ES540705A0 (es) Un procedimiento para la preparacion de 17b-carbamoil-n-monosustituido -o 17b-acil-4-aza-5-alfa-androstien-3-onas.
ES513221A0 (es) Un procedimiento para la preparacion de derivados de acidos alcanoicos.
ES541200A0 (es) Un procedimiento para la preparacion de un derivado de dibenzoilmetano.
ES546236A0 (es) Un procedimiento para la preparacion de derivados de bencimidasol.
ES513122A0 (es) Un procedimiento para la preparacion de hidantoinas.
ES540609A0 (es) Un procedimiento para la preparacion de pirazolo piridinas.
ES540610A0 (es) Un procedimiento para la preparacion de pirazolopiridinas.
ES544521A0 (es) Un procedimiento para la preparacion de triazolobenzodiazefinas.
ES546872A0 (es) Un procedimiento para la preparacion de aminoalcoxibenzopiranonas.
ES514264A0 (es) Un procedimiento para la preparacion de derivados de tiazolidi-nilalquilen-piperazinas.
ES512880A0 (es) Un procedimiento para la preparacion de derivados de 4-anilino-pirimidina.
ES509437A0 (es) Un procedimiento para la preparacion de derivados carbapenen-2-tio-sustituidos.
ES550504A0 (es) Un procedimiento para la preparacion de derivados de podofilotoxina.
ES544751A0 (es) Un procedimiento para la preparacion de -1-metilcarbapenems.
ES541781A0 (es) Un procedimiento para la preparacion de nuevos benzotiopenos.
ES515191A0 (es) "un procedimiento para la preparacion de sales de s-adenosilmetionina".
ES548797A0 (es) Un procedimiento para la preparacion de sales de imidazolio.
ES547805A0 (es) Un procedimiento para la preparacion de nuevos derivados de guanina.
ES513880A0 (es) Un procedimiento para la preparacion de derivados de triazolurea.
ES510611A0 (es) Un procedimiento para la preparacion de derivados de desoxiuridina.
ES513967A0 (es) Un procedimiento para la preparacion de derivados de etanola-mina.
ES547205A0 (es) Un procedimiento para la preparacion de nuevas quinazolindionas.